als < also < alter

Facettes : Author.f AffPays.f AffRegion.f AffVille.f AffOrg.f Mesh.f MeshFr.f Teeft.f

List of bibliographic references

Number of relevant bibliographic references: 72.
[0-20] [0 - 20][0 - 50][20-40]

Ident.	Authors (with country if any)	Title
000003 (2020)	Charlotte Girard-Guyonvarc'H ; Michele Iudici	[Targeted therapies for connective tissue diseases and vasculitis].
000006 (2020)	Anna Jakubczyc ; Claus Neurohr	[Interstitial lung disease in rheumatic diseases - new therapeutic approaches].
000007 (2020)	Danièle Allali ; Marc Blondon ; Pascale Roux-Lombard ; David Spoerl	[How to manage giant cell arteritis].
000030 (2020)	Gulzhan Trimova ; Kaoru Yamagata ; Shigeru Iwata ; Shintaro Hirata [Japon] ; Tong Zhang ; Fumi Uemura ; Minoru Satoh [Japon] ; Norma Biln ; Shingo Nakayamada ; Walter P. Maksymowych ; Yoshiya Tanaka	Tumour necrosis factor alpha promotes secretion of 14-3-3η by inducing necroptosis in macrophages
000034 (2020)	Angelika Batta ; Bhupinder Singh Kalra ; Raj Khirasaria	Trends in FDA drug approvals over last 2 decades: An observational study
000042 (2020)	Prakhar Vijayvargiya [États-Unis] ; Zerelda Esquer Garrigos [États-Unis] ; Natalia E. Castillo Almeida [États-Unis] ; Pooja R. Gurram [États-Unis] ; Ryan W. Stevens [États-Unis] ; Raymund R. Razonable [États-Unis]	Treatment Considerations for COVID-19: A Critical Review of the Evidence (or Lack Thereof)
000044 (2020)	Ernest H. Choy [Royaume-Uni] ; Fabrizio De Benedetti [Italie] ; Tsutomu Takeuchi [Japon] ; Misato Hashizume [Japon] ; Markus R. John [Suisse] ; Tadamitsu Kishimoto [Japon]	Translating IL-6 biology into effective treatments
000048 (2020)	Hazan Karadeniz [Turquie] ; Asl Han Avano Lu Güler [Turquie] ; Nuh Atas [Turquie] ; Hasan Sat [Turquie] ; Reyhan Bilici Salman [Turquie] ; Hakan Babaoglu [Turquie] ; Abdurrahman Tufan [Turquie]	Tofacitinib for the treatment for colchicine-resistant familial Mediterranean fever: case-based review.
000059 (2020)	Banafsheh Mosharmovahed [Iran] ; Yousef Fatahi [Iran] ; Bahareh Mohebbi [Iran] ; Sohrab Ali Ghorbanian [Iran] ; Sara Assadiasl [Iran]	Tocilizumab in transplantation.
000075 (2020)	Anca D. Askanase [États-Unis] ; Leila Khalili [États-Unis] ; Jill P. Buyon [États-Unis]	Thoughts on COVID-19 and autoimmune diseases
000079 (2020)	Caterina Vacchi [Italie] ; Marco Sebastiani [Italie] ; Giulia Cassone [Italie] ; Stefania Cerri [Italie] ; Giovanni Della Casa [Italie] ; Carlo Salvarani [Italie] ; Andreina Manfredi [Italie]	Therapeutic Options for the Treatment of Interstitial Lung Disease Related to Connective Tissue Diseases. A Narrative Review
000080 (2020)	Maria Valeria Catani ; Isabella Savini ; Valentina Tullio ; Valeria Gasperi	The “Janus Face” of Platelets in Cancer
000082 (2020)	Eun-Jung Park [Corée du Sud] ; Hyungjin Kim [Corée du Sud] ; Seung Min Jung [Corée du Sud] ; Yoon-Kyoung Sung [Corée du Sud] ; Han Joo Baek [Corée du Sud] ; Jisoo Lee [Corée du Sud]	The use of biological disease-modifying antirheumatic drugs for inflammatory arthritis in Korea: results of a Korean Expert Consensus
000086 (2020)	Christine Brostjan ; Rudolf Oehler	The role of neutrophil death in chronic inflammation and cancer
000089 (2020)	Jacob J. Adashek [États-Unis] ; Shumei Kato [États-Unis] ; Scott M. Lippman [États-Unis] ; Razelle Kurzrock [États-Unis]	The paradox of cancer genes in non-malignant conditions: implications for precision medicine
000105 (2020)	Peter J. Hotez ; Maria Elena Bottazzi ; David B. Corry	The Potential Role of Th17 Immune Responses in Coronavirus Immunopathology and Vaccine-induced Immune Enhancement
000109 (2020)	Eric Toussirot [France]	The Interrelations between Biological and Targeted Synthetic Agents Used in Inflammatory Joint Diseases, and Obesity or Body Composition
000110 (2020)	Anna Gluba-Brz Zka ; Beata Franczyk ; Robert Olszewski ; Jacek Rysz	The Influence of Inflammation on Anemia in CKD Patients
000134 (2020)	Ayush Gupta [Inde] ; Narendra Kumar Bagri [Inde] ; Saroj Kumar Tripathy [Inde] ; Adarsh Barwad [Inde] ; Ravi Hari Phulware [Inde] ; Pankaj Hari [Inde]	Successful use of tocilizumab in amyloidosis secondary to systemic juvenile idiopathic arthritis.
000140 (2020)	Yusho Ishii [Japon] ; Hiroshi Fujii [Japon] ; Koichiro Sugimura [Japon] ; Tsuyoshi Shirai [Japon] ; Yosuke Hoshi [Japon] ; Yoko Fujita [Japon] ; Yuko Shirota [Japon] ; Tomonori Ishii [Japon] ; Hiroaki Shimokawa [Japon] ; Hideo Harigae [Japon]	Successful Treatment of Pulmonary Arterial Hypertension in Systemic Sclerosis with Anticentriole Antibody
000161 (2020)	Shiyuan Wen [République populaire de Chine] ; Feng Wang [République populaire de Chine] ; Zhenhua Ji [République populaire de Chine] ; Yingyi Pan [République populaire de Chine] ; Miaomiao Jian [République populaire de Chine] ; Yunfeng Bi [République populaire de Chine] ; Guozhong Zhou [République populaire de Chine] ; Lisha Luo [République populaire de Chine] ; Taigui Chen [République populaire de Chine] ; Lianbao Li [République populaire de Chine] ; Zhe Ding [République populaire de Chine] ; Manzama-Esso Abi [République populaire de Chine] ; Aihua Liu [République populaire de Chine] ; Fukai Bao [République populaire de Chine]	Salp15, a Multifunctional Protein From Tick Saliva With Potential Pharmaceutical Effects

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/2020/Analysis

HfdIndexSelect -h $EXPLOR_AREA/Data/2020/Analysis/AbsEn.i -k "also" 

HfdIndexSelect -h $EXPLOR_AREA/Data/2020/Analysis/AbsEn.i  \
                -Sk "also" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/2020/Analysis/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    2020
   |étape=   Analysis
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    also
}}

---

This area was generated with Dilib version V0.6.34. Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021